Abstract:The genetics of peripheral T cell lymphomas (PTCL) are poorly understood. Recently, a chromosomal translocation, t(5;9)(q33;q22), was discovered in a rare subset of PTCL with a follicular growth pattern. This translocation involved the SYK (Spleen tyrosine kinase) and ITK (Inducible T cell kinase) genes and generated an ITK-SYK fusion protein. The functional attributes of ITK-SYK are thus far uncharacterised. Here we demonstrate that ITK-SYK is an active tyrosine kinase, the expression of which resulted in ERK activation in 293T cells and transformation of NIH-3T3 cells, inducing loss of contact inhibition and formation of anchorage-independent colonies in soft agar. These observations were a direct result of the kinase activity of ITK-SYK as a kinase dead mutant was unable to induce NIH-3T3 transformation or phosphorylation of ERK. ITK-SYK is unusual amongst fusion tyrosine kinases (FTKs) as it does not contain a known oligomerisation domain but does have an N-terminal phosphatidylinositol-3,4,5-trisphosphate (PIP3)-binding pleckstrin homology (PH) domain. To investigate the importance of this domain for ITK-SYK activity we introduced a well characterised point mutation (R29C) that prevented membrane localisation. This point mutation abrogated ITK-SYK catalytic activity and inhibited its phosphorylation on its activation loop tyrosines in the kinase domain. Importantly, the R29C mutation also prevented the ability of ITK-SYK to activate the ERK signaling pathway and to transform NIH3T3 cells. However, each of these functions could be recovered by retargeting ITK-SYK-R29C back to the membrane by the addition of an N-terminal myristylation tag, thus demonstrating the importance of membrane localisation for ITK-SYK function. Furthermore, inhibition of phosphatidyl-inositol-3-kinase (PI3K) by LY294002, a well characterised PI3K inhibitor, also reduced ITK-SYK phosphorylation in a dose dependent response. Therefore, ITK-SYK activation requires PIP3 mediated membrane localisation, as seen with other PH domain containing kinases. Finally, we show that pharmacological inhibition of Syk in patients with PTCL-U carrying ITK-SYK could represent an effective treatment strategy as ITK-SYK phosphorylation was inhibited by the Syk inhibitor Piceatannol. Together these findings identify ITK-SYK as an active FTK, that is dependent upon PH domain-mediated membrane localisation for activation, signal transduction and transformation and establish it as a rational therapeutic target for t(5;9)(q33;q22)-positive PTCL. Citation Information: In: Proc Am Assoc Cancer Res; 2009 Apr 18-22; Denver, CO. Philadelphia (PA): AACR; 2009. Abstract nr 447.

SYK is upstream of phosphoinositide 3-kinase in B cell receptor signaling

The SYK side of TLR4: signalling mechanisms in response to LPS and minimally oxidized LDL

Role of Phosphatidylinositol 3-Kinase and Specific Protein Kinase B Isoforms in the Suppression of Apoptosis Mediated by the Abelson Protein-tyrosine Kinase

Syk regulation of phosphoinositide 3-kinase-dependent NK cell function

Acute Csk Inhibition Hinders B Cell Activation by Constraining the PI3 Kinase Pathway.

Regulation of cytokine-independent survival kinase (CISK) by the Phox homology domain and phosphoinositides

Syk protein tyrosine kinase involves PECAM-1 signaling through tandem immunotyrosine inhibitory motifs in human THP-1 macrophages

Coordinated Regulation of the Tyrosine Phosphorylation of Cbl by Fyn and Syk Tyrosine Kinases

SYK and ZAP70 kinases in autoimmunity and lymphoid malignancies

The SYK tyrosine kinase: a crucial player in diverse biological functions

BCR targets cyclin D2 via Btk and the p85|[alpha]| subunit of PI3-K to induce cell cycle progression in primary mouse B cells

BCR targets cyclin D2 via Btk and the p85 α subunit of PI3-K to induce cell cycle progression in primary mouse B cells

In BTK, phosphorylated Y223 in the SH3 domain mirrors catalytic activity, but does not influence biological function

Regulation of phospholipase C-gamma2 and phosphoinositide 3-kinase pathways by adaptor proteins in B lymphocytes

Syk Inhibits the Activity of Protein Kinase A by Phosphorylating Tyrosine 330 of the Catalytic Subunit

Itk-Syk Requires Membrane Localisation, Via Its Pleckstrin Homology Domain, for Activation, Signal Transduction and Cellular Transformation

PI3K- and PTEN-Governed PIP2 and PIP3 Equilibrium Regulates the Activation and Function of B Cells Through Dock2 Controlled Growth of Antigen Receptor Microclusters

Syk is indispensable for CpG-induced activation and differentiation of human B cells

Protein Kinase C Activation Inhibits Tyrosine Phosphorylation Of Cbl And Its Recruitment Of Src Homology 2 Domain-Containing Proteins

Phosphorylation of (Ser 291) in the linker insert of Syk negatively regulates ITAM signaling in platelets

PU.1 and Spi-B are required for normal B cell receptor-mediated signal transduction